申请人:Chandrakumar Nizal
公开号:US20050176821A1
公开(公告)日:2005-08-11
The present invention relates to a class of compounds represented by the Formula I
or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the α
v
β
3
integrin.
本发明涉及一类由式 I
或其药学上可接受的盐、包含式 I 化合物的药物组合物,以及选择性抑制或拮抗 α
v
β
3
整合素的方法。